Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

AKI—A Relevant Safety End Point?

American Journal of Kidney Diseases(2020)10.1053/j.ajkd.2019.11.010Source: DataRank Database

AKI—A Relevant Safety End Point? is a research paper published in American Journal of Kidney Diseases (2020). On theSindex it has a DataRank of 0. It has been cited 20 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access20 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)OA: greenTopics (30)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Glenn M. Chertow ORCID,Ian E. McCoy ORCID

Live enrichment

PubMed:32037098 PMC:PMC7092818

NIDDK NIH HHS

Grant: K24 DK085446

NIDDK NIH HHS

Grant: T32 DK007357

National Institutes of Health

Grant: 5K24DK085446-07

Mentoring Patient-Oriented Clinical Investigators in Nephrology

National Institutes of Health

Grant: 5T32DK007357-27

Adult and Pediatric Nephrology Research Training Program

National Institute of Diabetes and Digestive and Kidney Diseases

greenLicense: Elsevier TDM

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7092818

publisherhttps://api.elsevier.com/content/article/PII:S0272638619311680?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0272638619311680?httpAccept=text/plain

https://doi.org/10.1053/j.ajkd.2019.11.010

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092818

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansCreatinineEndpoint DeterminationRandomized Controlled Trials as TopicAcute Kidney Injury

Keywords

SafetyHemodynamicsPrognosisBiomarkerKidney damageClinical TrialsBlood Pressure ControlKidney FunctionAcute Kidney Injury (Aki)Safety SignalSurrogate OutcomeAcute Renal Failure (Arf)Serum Creatinine (Scr)Trial End PointMajor Adverse Kidney Events (Make)Acute Decompensated Heart Failure (Adhf)Aki DefinitionPatient-centered Outcome (Pco)Endpoint DeterminationCreatinineHumansAcute Kidney InjuryRandomized Controlled Trials as Topic

Sustainable Development Goals

SDG 3: 3. Good health